Rucaparib boosts progression-free survival in BRCA mutant recurrent ovarian cancer
LUGANO-MADRID, 8 September, 2017 - Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the...






